The antigenic composition of Cryptococcus neoformans. II. Serologic studies with the capsular polysaccharide.
作者信息
EVANS E E, KESSEL J F
出版信息
J Immunol. 1951 Aug;67(2):109-14.
PMID:14861422
Abstract
摘要
相似文献
1
The antigenic composition of Cryptococcus neoformans. II. Serologic studies with the capsular polysaccharide.
J Immunol. 1951 Aug;67(2):109-14.
2
3
Specific degradation of Cryptococcus neoformans 3723 capsular polysaccharide by a microbial enzyme. II. Biological activity of the enzyme.
J Infect Dis. 1960 Nov-Dec;107:402-5. doi: 10.1093/infdis/107.3.402.
4
Specific degradation of Cryptococcus neoformans 3723 capsular polysaccharide by a microbial enzyme. III. Antibody stimulation by partially decapsulated cells.
J Infect Dis. 1960 Nov-Dec;107:406-9. doi: 10.1093/infdis/107.3.406.
5
CRYPTOCOCCUS NEOFORMANS POLYSACCHARIDE: STUDIES OF SEROLOGIC PROPERTIES AND ROLE IN INFECTION.
J Immunol. 1965 Jun;94:916-20.
6
Specific degradation of Cryptococcus neoformans 3723 capsular polysaccharide by a microbial enzyme. I. Isolation, partial purification, and properties of the enzyme.
Can J Microbiol. 1961 Feb;7:53-60. doi: 10.1139/m61-007.
7
Antigenic structure of Cryptococcus neoformans capsular polysaccharides.
Immunol Ser. 1989;47:63-86.
8
Structural studies of the capsular polysaccharide of a non-neoformans Cryptococcus species identified as C. laurentii, which was reclassified as Cryptococcus flavescens, from a patient with AIDS.
Carbohydr Res. 2004 Feb 25;339(3):503-9. doi: 10.1016/j.carres.2003.11.015.
9
Structure and antigenic activity of the capsular polysaccharide of Cryptococcus neoformans serotype A.
Mol Immunol. 1980 Aug;17(8):1025-32. doi: 10.1016/0161-5890(80)90096-6.
10
The antigenic compostion of Cryptococcus neoformans. IV. The use of paper chromatography for following purification of the capsular polysaccharide.
J Bacteriol. 1953 May;65(5):571-7. doi: 10.1128/jb.65.5.571-577.1953.
引用本文的文献
1
Surface glycans of Candida albicans and other pathogenic fungi: physiological roles, clinical uses, and experimental challenges.
Clin Microbiol Rev. 2004 Apr;17(2):281-310. doi: 10.1128/CMR.17.2.281-310.2004.
2
A case of cryptococcal meningitis.
J Clin Pathol. 1955 Feb;8(1):32-7. doi: 10.1136/jcp.8.1.32.
3
Specific and non-specific immunity in experimental cryptococcosis in mice.
J Exp Med. 1960 May 1;111(5):643-65. doi: 10.1084/jem.111.5.643.
4
Rapid production of complement fixation antigens for systemic mycotic diseases. I. Coccidioidin: influence of media and mechanical agitation on its development.
J Bacteriol. 1959 Jun;77(6):753-6. doi: 10.1128/jb.77.6.753-756.1959.
5
6
[A critical review of medical mycology in the United States 1946-1956].
Mycopathol Mycol Appl. 1957 Dec 20;8(4):271-326. doi: 10.1007/BF02052297.
7
The antigenic composition of Cryptococcus neoformans. V. A survey of cross-reactions among strains of Cryptococcus and other antigens.
J Bacteriol. 1953 Sep;66(3):287-93. doi: 10.1128/jb.66.3.287-293.1953.
8
The antigenic compostion of Cryptococcus neoformans. IV. The use of paper chromatography for following purification of the capsular polysaccharide.
J Bacteriol. 1953 May;65(5):571-7. doi: 10.1128/jb.65.5.571-577.1953.
9
Prevalence of Cryptococcus neoformans var. neoformans (Serotype D) and Cryptococcus neoformans var. grubii (Serotype A) isolates in New York City.
J Clin Microbiol. 2000 May;38(5):1974-6. doi: 10.1128/JCM.38.5.1974-1976.2000.
10
Serotyping of Cryptococcus neoformans isolates from clinical and environmental sources in Spain.
J Clin Microbiol. 1999 Apr;37(4):1170-2. doi: 10.1128/JCM.37.4.1170-1172.1999.
Zotero 插件